Overview

Modulation of Regional Brain Activation in Schizophrenic Patients by Pharmacological Therapy

Status:
Terminated
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
The study aims to investigate the modulation of regional brain activation in schizophrenic patients by psychopharmacological treatment with either haloperidol, amisulpride or olanzapine. The study will be performed with functional magnetic resonance imaging (fMRI) and diffusion tensor imaging (DTI).
Phase:
Phase 4
Details
Lead Sponsor:
University of Jena
Collaborator:
Sanofi
Treatments:
Amisulpride
Haloperidol
Haloperidol decanoate
Olanzapine
Sulpiride
Sultopride